34 Views | 21 Downloads
Alexis N. Simpkins
alexis.simpkins@neurology.ufl.edu
The Neurotherapeutics Symposium 2019: Edilberto Amorim, Carolina Barnett-Tapia, Jeremy Brown, Katharina M. Busl, Mackenzie Cervenka, Jan Claassen, Monica Dhakar, Layne Dylla, Marie-Carmelle Elie, Mark Etherton, Kevin Fiscella, Brandon Foreman, Peter Forgacs, Robert C. Griggs, Marc Halterman, Andrea Harriott, Lawrence J. Hirsch, Sara Hocker, Robert Holloway, Rebecca Jules, Adam G. Kelly, Daniel Lackland, Mackenzie P. Lerario, Karlo J. Lizarraga, Carolina B. Maciel, Lisa H. Merck, Gordon Mitchell, Laura B. Ngwenya, Raul G. Nogueira, Clifford Pierre, Javier Provencio, Alejandro A. Rabenstein, Debra Roberts, Clio Rubinos, Eugene Scharf, Kevin N. Sheth, Alexis N. Simpkins, Cleopatra Thurman, Lauren Ullrich, and Christopher Zammit.
We appreciate the contribution and presentations from the speakers and moderators at the conference, including: Edilberto Amorim, MD (University of California San Francisco, Harvard Medical School, Massachusetts Institute of Technology); Carolina Barnett-Tapia, MD, PhD (University Health Network—Toronto General Hospital); Jeremy Brown, MD (Office of Emergency Care Research NIH); Katharina M. Busl, MD, MS (University of Florida); Mackenzie Cervenka, MD (Johns Hopkins University); Jan Claassen, MD, PhD (Columbia University Medical Center); Monica Dhakar, MD, MS (Emory University); Layne Dylla, MD (University of Rochester); Marie-Carmelle Elie, MD, RDMS (University of Florida); Mark Etherton, MD, PhD (Harvard Medical School); Kevin Fiscella, MD, MPH (University of Rochester); Brandon Foreman, MD (University of Cincinnati); Peter Forgacs, MD (Weill Cornell Medical College); Robert C Griggs (University of Rochester); Marc Halterman, MD, PhD (University of Rochester); Andrea Harriott, MD, PhD (Harvard Medical School); Lawrence J Hirsch (Yale University); Sara Hocker, MD (Mayo Clinic); Robert Holloway (University of Rochester); Rebecca Jules (University of Florida); Adam G. Kelly (University of Rochester); Daniel Lackland, Dr. PH (Medical University of South Carolina); Mackenzie P Lerario, MD (Weill Cornell Medical College); Karlo J. Lizarraga, MD, MS (University of Rochester); Carolina B. Maciel, MD, MSCR (University of Florida, University of Utah, Yale University); Lisa H. Merck, MD, MPH (University of Florida); Gordon Mitchell, PhD (University of Florida); Laura B. Ngwenya, MD, PhD (University of Cincinnati); Raul G. Nogueira, MD (Emory University); Clifford Pierre, MD (University of Rochester); Javier Provencio, MD, PhD (University of Virginia); Alejandro A. Rabenstein, MD (Mayo Clinic); Debra Roberts, MD, PhD (University of Rochester); Clio Rubinos, MD (University of North Carolina); Eugene Scharf, MD (Mayo Clinic); Kevin N. Sheth, MD (Yale University); Alexis N. Simpkins, MD, PhD, MSCR (University of Florida); Cleopatra Thurman, MD (University of Michigan); Lauren Ullrich, MS, PhD (NINDS); Christopher Zammit, MD (University of Rochester). We also want to thank Franklin D. Echevarria, PhD (University of Florida) for assistance with manuscript submission and formatting.
Dr. Simpkins has nothing to disclose; Dr. Busl reports personal fees from Guidepoint Global, personal fees from Techspert, other from American Academy of Neurology, outside the submitted work; Dr. Amorim has nothing to disclose; Dr. Barnett reports grants from Octapharma, grants from Grifols, personal fees from Alexion, personal fees from Takeda, personal fees from Akcea, personal fees from CSL, outside the submitted work; Dr. Cervenka reports grants and personal fees from Nutricia, grants from Vitaflo, grants from BrightFocus Foundation, personal fees from Demos, personal fees from Glut2 Deficiency Foundation, outside the submitted work; Dr. Dhakar reports personal fees from Adamas Pharmaceuticals, outside the submitted work; Dr. Etherton has nothing to disclose; Ms. Fung has nothing to disclose; Dr. Griggs reports grants from Strongbridge Biopharma, grants from Attune Medical, during the conduct of the study; grants from PTC Therapeutics (formerly Marathon Pharma), grants from Sarepta Therapeutics, grants from Foundation to Eradicate Duchenne (FED), grants from Muscular Dystrophy Association (MDA), grants from Parent Project Muscular Dystrophy (PPMD), outside the submitted work; Dr. Holloway has nothing to disclose; Dr. Kelly has nothing to disclose; Dr. Khan has nothing to disclose; Dr. Lizarraga has nothing to disclose; Ms. Madagan has nothing to disclose; Dr. Merck reports grants from NIH, grants from DoD, grants from Bill and Melinda Gates Foundation, outside the submitted work; Dr. Mestre has nothing to disclose; Dr. Rabinstein has nothing to disclose; Dr. Rubinos has nothing to disclose; Dr. Youn has nothing to disclose; Dr. Maciel has nothing to disclose.
See publication for full list of authors.
NINDS (R13 NS11956-01), the McKnight Brain Institute and industry (Sophysa, UCB, Moberg, Persyst, NeurOptics, GW Pharmaceuticals, Minnetronix Neuro, Strongbridge, Raumedics, Attun).
© The Author(s) 2020.